PetMed Express (PETS) Receives News Sentiment Rating of 0.19

News articles about PetMed Express (NASDAQ:PETS) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. PetMed Express earned a daily sentiment score of 0.19 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.8861194207749 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the headlines that may have impacted Accern Sentiment’s analysis:

PetMed Express (PETS) opened at $45.64 on Friday. The company has a market cap of $949.24, a price-to-earnings ratio of 30.63, a price-to-earnings-growth ratio of 2.74 and a beta of 1.13. PetMed Express has a one year low of $19.21 and a one year high of $50.90.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, October 23rd. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. The company had revenue of $66.70 million for the quarter, compared to analyst estimates of $63.41 million. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. PetMed Express’s quarterly revenue was up 9.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.24 earnings per share. research analysts forecast that PetMed Express will post 1.68 EPS for the current fiscal year.

Several equities research analysts recently commented on PETS shares. ValuEngine upgraded shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Noble Financial restated a “hold” rating on shares of PetMed Express in a research note on Friday, October 27th. Zacks Investment Research upgraded shares of PetMed Express from a “sell” rating to a “hold” rating and set a $50.00 price objective on the stock in a research note on Friday, October 20th. BidaskClub upgraded shares of PetMed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. Finally, Credit Suisse Group restated an “underperform” rating and issued a $19.00 price objective on shares of PetMed Express in a research note on Monday, October 2nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $42.00.

In other news, Director Ronald J. Korn sold 1,000 shares of PetMed Express stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $35.57, for a total value of $35,570.00. Following the sale, the director now owns 73,833 shares of the company’s stock, valued at $2,626,239.81. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Gian Fulgoni sold 20,000 shares of PetMed Express stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $44.38, for a total transaction of $887,600.00. Following the completion of the sale, the director now directly owns 55,900 shares in the company, valued at approximately $2,480,842. The disclosure for this sale can be found here. 4.00% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.com-unik.info/2017/12/23/petmed-express-pets-receives-news-sentiment-rating-of-0-19.html.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Insider Buying and Selling by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit